Salipdan, Princess Kate Ella C.

HRN: 25-73-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2024
CEFUROXIME 750MG (VIAL)
12/17/2024
12/23/2024
IV
435 Mg
Q8H
PCAP C
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes